Investment
Features
FeesSafety
Academy
More
Pluang+

Concentrix earnings preview shows stable revenue but mixed EPS forecasts ahead of Sept 29 report.

Company Fundamentals
29 Sep 2026
Gordon Thompson
View Source
Neutral
Concentrix earnings preview shows stable revenue but mixed EPS forecasts ahead of Sept 29 report.

Concentrix Corporation is set to release its earnings report on September 29, 2026, with revenue expected to remain stable at $2.48 billion, matching last year's quarter. However, analysts have differing views on earnings per share (EPS), with estimates ranging from $2.71 to $2.81, indicating uncertainty about profit growth. The company recently acquired CastleHill Managed Risk Solutions and offers a 5.32% annual dividend yield, factors that investors will consider alongside the earnings results. The upcoming report will be closely watched as it may influence Concentrix's stock price based on how actual results compare to forecasts.

Concentrix earnings preview notes a 5.32% annual dividend yield as a key stat. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 29, 2026 19:33 WIB: out of 150 priced US Technology stocks, 88 rose and 53 fell. Notable movers include IREN at USD 42.55 (+1.99%), KLAC at USD 192.79 (+1.91%), and ASML at USD 1,803.00 (+1.78%), with typical hold times ranging from 26 to 92 days and Pluang order activity showing more selling than buying in these names.

More News

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix stock rises after Deutsche Bank upgrades it amid mixed analyst opinions.

Netflix shares rose 1.5% after Deutsche Bank upgraded the stock from Hold to Buy, citing recent price declines as a buying opportunity and stronger international trends. However, other analysts remain cautious, with Wells Fargo downgrading Netflix to...

Analyst Insights
Bullish
2 hours ago
Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics insiders, including CEO, sell significant shares amid stock trading below moving averages.

Cytokinetics' CEO Robert I. Blum and other executives have recently sold large amounts of company stock, with Blum selling nearly 105,000 shares in total, including a major block under a pre-arranged trading plan. This insider selling occurs while th...

Market News
Bearish
2 hours ago
Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival posts strong quarterly earnings with $1.92B net income amid rising cruise demand

Carnival Corporation reported strong quarterly results with earnings per share of $1.43 and net income of $1.92 billion, surpassing analyst expectations. The company achieved record revenue of $8.44 billion, driven by growing consumer interest in cru...

Company Fundamentals
Bullish
2 hours ago
FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet expects strong Q3 earnings with $4.35 EPS and $630M revenue, driven by AI demand and cost control.

FactSet is set to report strong Q3 earnings with an expected EPS of $4.35 and revenue around $629.83 million, reflecting a 5.3% increase from last year. The company benefits from high demand for AI-related products, expanded client base, and effectiv...

Company Fundamentals
Bullish
2 hours ago
Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies posts strong Q3 with $1.09 EPS and $2.22B revenue, signaling 50% stock upside potential.

Jefferies Financial Group reported robust Q3 results with earnings per share of $1.09, beating analyst estimates and last year's $1.05. Revenue rose to $2.22 billion, driven by record banking revenue, surpassing expectations. Net earnings increased t...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App